Dehydroabietyl-ethylenediamine



United States nnHYDRoABmTYL-nrmnmnmm No Drawing. Application July 2, 1956, Serial No. 595,093

1 Claim. (Cl. 260-102) This invention relates to a new class of organic chemicals useful in therapeutics and in the manufacture of streptomycins and, more particularly, to new 1,3-substituted-2-streptomycyl-tetrahydroimidazoles and their nontoxic salts.

This application is a division of my prior co-pending application Serial Number 338,129, filed February 20, 1 53.

Throughout this specification and claim, the names streptomycyl and hydroxystreptomycyl are used to represent the radicals attached to the aldehyde group H in the widely-known antibiotics streptomycin and hydroxystreptomycin. Thus, the antibiotic streptomycin is represented by the formula Streptomycyl-CHO or as Strep.Cl-IO (see U. S. Patent #2,607,770) rather than by the customary formula. An ordinary salt, such as the sulfate, is represented as Streptomycyl-CHO 1 /2 H2804 or as 2 Streptomycyl CHO 3 H2504.

Up to the present time, there have not been available any active, non-toxic salts or forms or derivatives of streptomycin which are relatively insoluble in water. In chemical production, this means that elaborate processes, such as those using ion-exchange columns, are required to concentrate a solution of crude streptomycin. Final crystallization is a complex and expensive process using large amounts of organic solvents and generally also requiring formation of a calcium-chloride double salt before a satisfactory crystalline sulfate can be prepared. Illustrative processes are given by U. S. Patents #2,446,102, 2,541,420 and 2,578,840. Expensive toxic dyes are used by Regna; see U. S. Patents 2,555,762, 2,555,763, 2,560,889, 2,560,890, 2,555,761, 2,555,760.

A further disadvantage of known salts and derivatives of streptomycin and the free base in their instability under alkaline conditions, which irreversibly decompose and inactivate the streptomycin, forming the gammapyrone, maltol.

In therapeutic use, present water-soluble salts and derivatives of streptomycin and the free base are rapidly absorbed when administered by injection, e. g. intramuscularly, and do not give protracted blood levels. They are also absorbed very poorly upon oral administration. In the treatment of tuberculosis, prolonged high concentrations of streptomycin are not necessary and in addition increase the possibilities of neurotoxic reactions (Antibiotic Therapy, Welch and Lewis, Arundel Press, Washington, D. C., 1951, page 104). A repository preparation giving prolonged but not too high blood levels is therefore desired to overcome these objectives and to spare the patient and physician the inconvenience and expense of numerous injections.

It is an object of the present invention to provide a new series of derivatives of streptomycin and hydroxystreptomycin and their acid addition salts, which are nontoxic, therapeutically effective, relatively insoluble in atent 2,767,161 Patented Oct. 16, 1956 provide prolonged blood levels and prolonged therapeutic action.

It is an additional object of the present invention to provide a new series of derivatives of streptomycin and hydroxystreptomycin and their non-toxic acid addition salts which are systemically absorbed and effective upon oral or buccal, e. g. sublingual, administration.

The objects of this invention have been achieved and there is now discovered, according to the present invention, the new series of compounds selected from the group consisting of compounds having the Formula (a) CHCH R I I I l-R,

C Eitreptomycyl wherein R1 and R2 represent radicals selected from the group consisting of alkyl, cyclopentyl, cyclopentyl-lower alkyl, cyclohexyl, cyclohexyl-lower alkyl, lower alkylcyclohexyl-lower alkyl, lower alkoxy-cyclohexyl-lower alkyl, lower alkyl-cyclohexyl, lower alkoxy-cyclohexyl, dehydroabietyl-lower alkyl, pyridyl, pyridyl lower alkyl, lower alkyl-pyridyl-lower alkyl, thiophene-lower alkyl, lower alkyl-thiophene-lower alkyl, furan-lower alkyl, lower alkyl-furan-lower alkyl, quinolyl-lower alkyl, naphthyl, benzhydryl, piperonyl, thiazolyl, phenyl, lower alkylphenyl-lower alkyl, phenyl-lower-alkyl, halophenyllower alkyl, dihalophenyl-lower alkyl, nitrophenyl-lower alkyl, hydroxyphenyl-lower alkyl, HzN-phenyl-lower alkyl, lower alkoXy-phenyl-lower alkyl, di-lower alkoxyphenyl-lower alkyl, lower alkylphenyl-lower alkyl, alkoxy-hydroxy-phenyl-lower alkyl, and di-lower alkylmonohydroxyphenyl-lower alkyl; R3 and R4 are members selected from the group consisting of hydrogen and methyl; and (b) acid addition salts thereof.

The products of the present invention are useful, nontoxic therapeutic agents in diseases of man and animals caused by streptomycin-sensitive tuberculosis bacteria and gram-negative bacteria and are useful as growthstimulating supplements for animals and poultry, as in feeds, and for use to stimulate the growth of plants, such as radishes, oats and grass.

Further, as illustrated in detail below, the products of the present invention are of particular value in the commercial production of streptomycin because, by virtue of their very low solubility in water and other solvents, they provide improved means for isolation and purification of streptomycin from impurities, e. g. ash-forming impurities.

The products of the present invention are further useful for their ability to provide prolonged, therapeutic blood-levels upon parental injection in comparison with the non-toxic streptomycin salts of the prior art.

The products of the present invention are prepared by the reaction of hydroxystreptomycin free base, streptomycin free base or water-soluble acid addition salts thereof, and I prefer streptomycin sulfate, with an equimolar quantity, or more, of an N,N-substituted-a,,3-diaminoalkane, where there are two to four carbon atoms in the alkane carbon chain. Two examples are N,N-dibenzylethylenediamine and N-p-methylbenzyl-N'-benzyl-1,2-diaminopropane. I prefer to conduct the reaction in Water but can also use a mixture of water and a water-miscible organic solvent such as methanol or acetone when desired, e. g. to solubilize. the amine. The reaction takes place at room temperature over a period varying from several hours to several days but can be accelerated by heating, e. g. to 50 C. for twenty minutes. 'I'he'mixture needs to be maintained at a pH of about 7.0 or higher, since acid conditions reverse the reaction and regenerate the starting reagents. The product precipitates as a solid or as an oil which solidifies on seeding. The product may be purified of unreacted streptomycin reagent, i. e. sulfate, by slurrying with water. 7 a

Brief heating in aqueous acid regenerates the starting materials andoften precipitates the diamine salt, e. g. N,N-dibenzylethylenediamine. hydrochloride. The purified streptomycin can be recovered in the usualways, as

by lyophilization or by crystallization of the sulfate by the addition of alcohol. V a a This invention also includes all acid addition salts for processing purposes and all non-toxic acid addition salts for therapeutic purposes, organic and inorganic examples of which include hydrochloric, sulfuric, 'sulfamic, tartaric, hydrobromic, hydriodic, glycolic, citric, maleic, phosphoric, succinic, acetic, benzoic, cinnamic, mandelic, malic, ascorbic, and the like. I prefer the sulfate.

When the imidazoles of the present invention are used for therapeutic purposes, they may be used in water with a suspending agent such as sodium carboxymethylcellulose, Spans, Tweens, lecithin or pectin or in injectable oils, e. g. peanut oil gelled with aluminum mouostearate in a manner analogous to the art pertaining to insoluble salts of penicillin. If desired, suspending or dispensing agents may be added to increase pharmaceutical elegance. As a suspending or dispersing-agent, sodium carboxymethyicellulose has been found highly satisfactory but carboxymethylcellulose, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, gum tragacanth, gelatin, pectin, sodium alginates, dextran, gum Karaya, the copolymer of methyl vinyl ether and maleic anhydride, andthe like, are also useful. The amount of suspending agent will vary to a certain extent, but usually from about 0.2 to 5.0 percent, preferably from 0.5 to 2.5 percent, is employed and variations within these ranges may be made by any experienced chemist or pharmacist with regard to themtended use of the composition. Thus the" concentration of polyvinyl'pyrrolidone may vary from 0.1% to 25%, with about 10% preferred. The concentration of dextran may vary from 0.1% to 20%, with about 10% preferred. The concentration of pectin may vary from 0.1% to 0.5 with about 0.2% preferred. The concentration of gum tragacanth may vary from 0.5% to 2% with about 1% preferred; sodium chloride may be added thereto.

It is to be understood that the words suspending agent and dispersing agent are used interchangeably to describe the additives such as sodium carboxymethylcellulose, lecithin, Spans and Tweens which improve the pharmaceutical elegance of these preparations, as by increasing ease of injection and ease of resuspension upon settling. Other suspending and dispersing agents include lecithin, Falba, cholesterol, Span 20, Span 40, Span 60, Span 80, the Tweens, Amerchols, sodium alginate, potassium alginate, ammonium alginate, calcium alginate, alginic acid, propylene glycol alginate, polyoxyalkylene derivatives of sorbitol fatty acid esters, urea and sodium p-aminobenzoate.

The composition is not limited to the exact ingredients previously described and to the exclusion of all others, since various other ingredients, While not necessary, may be added, if desired. For instance, a small amount of preservative, such as Phenol U. S. P., Cresol U. S. P., -Methyl Paraben (methyl ester of p-hydroxybenzoic acid), Ethyl Paraben (ethyl ester of p-hydroxybenzoic acid), Butyl Paraben (butyl ester of p-hydroxybenzoic acid) or Propyl Paraben (propyl ester of p-hydroxybeuzoic acid) may be employed. Other ingredients which improve blood levels, handling properties and stability may be added. Examples of such ingredients are lecithin, Falba, cholesterol, Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60, Tween 80, Tween 85, Amerchols, urea, and sodium para-amino-benzoate. 'The Spans are hexitol anhydride (hexitans and hexides derived from sorbitol) partial esters of common long-chain fatty acids (e. g. lauric, palmitic, stearic, olei'c) and the Tweens are polyoxyalkylene derivatives of the Spans.

The diamine reagents of this invention are prepared by the usual synthetic methods; Thus by the reaction of ethylene dichloride with an appropriately substituted amine, substituted ethylene diamines are formed. Alternatively, ethylene diamine or its acid addition salts are reacted with formaldehyde and a suitably substituted compound containing an active hydrogen-atom; such as aldehydes, ketones, thiophene, organic acids and the like, whereby N,N'-disubstituted ethylene diamines are obtained. In another method for the preparation of substituted ethylene diamines, asuitably substituted aldehyde or ketone is condensed with ethylene diamine to form the correspondingly substituted diimine. The diimine is hydrogenated by the usual methods, such as catalytic reduction and the like, to give the desired'substituted ethylene diamine. Acid addition salts of the substituted ethylene j diamines canbe prepared by the methods of the art, as, for example, by inter-reaction of equivalent amounts of the substituted diamine base and a selected acid in inert solvent solution, followed by removal of the solvent.

Thus l,2-bis-(phenylethylamino)ethane is prepared by' mixing a solution of 54 g. (0.5 mole) of l,2-dibromoeth-. ane in 250 cc. of ethanol and 242 g. (2 moles) of Z-phenylethylamine. The mixture is boiled for about an hour, made alkaline with potassium hydroxide and boiled for a further 10-minute period. The precipitated potassium bromide is removed, the alcohol is evaporated off and the residue, comprising 1,2-bis-(phenylethylamino)ethane, is fractionally distilled under pressure. 1,2-bis-(phenylethylamino)ethane boils at about 240 C. at the pressure of 15 mm. of mercury.

Thus, in a 500 ml. three-necked flask, fitted with stirrer, condenser and thermometer, are mixed 42 g. (0.5 mole) of thiophene, 33 g. (0.25 mole) ethylenediamine dihydrochloride and 43 ml. of 36% aqueous formaldehyde. The mixture is stirred and heated to gradually raise the temperature. At C. a vigorous reactionbegins, heating is stopped and an ice-bath is applied to the'flask. The internal temperature rises to about 73 C. and the reaction mixture solidifies. 200 ml. of 50% aqueous alcohol is added and stirred and the mixture is heated an additional minutes. After cooling, the reaction product is filtered and Washed with water. The White product is amorphous and is dissolved in 250 ml. hot water, cooled and made alkaline with 40% sodium hydroxide. The

, free base which separates is not very soluble in ether and is taken up in benzene, dried over sodium hydroxide and is obtained as a colorless, viscous oil on removing benzene in vacuo. The oil is converted to diacetate by dissolving in 200 ml. ethyl acetate and adding 12 ml. glacial acetic acid. The precipitated N,N'-bis-(2-thenyl)- ethylenediamine diacetate is collected by filtration, washed with ethyl acetate and found to melt at about 84 C.

v In essentially the same manner as above, one may also react an alkylene diamine such as ethylenediamine and an acid, as, for example, hydrochloric, sulfuric or formic acid, to form the diacid salt together with half a mol. of formaldehyde, half a mol. of the following compounds may be reacted therewith to form the corresponding symmetrical di-substituted alkylene diamines: cyclohexanone, 2,3 and 4-methyl-cyclohexanone, 4-methoxycyclohexanone, cyclopentanone, Z-methyl-thiophene, isoquinoline, 3-methyl-is oquinoline and quinaldine. v 7 M l /d N,N' mono-substituted-ethylene diamines may be prepared in the ways known tothe art. Thus, to prepare N-benzyl-N'-alpha-ethylbenzylethylenediamine, dimethyl benzylaminoacetal (49 g., 0.25 mol.) and 1 phenylpropylamine (34 g., 0.25 mol.) are mixed in a 500 ml. flask fitted with a reflux condenser with a drying tube. Formic acid (75 ml., 98l00%) is added all at once. A vigorous reaction ensues with darkening and evolution of heat and of carbon dioxide. When the initial vigorous reaction has subsided, the mixture is heated to reflux for two hours and excess formic acid is then removed by distillation under reduced pressure to leave a tarry residue to which is added 150 ml. of 6 N HCl. After heating for reflux for one hour, cooling in an icebath and making alkaline by the addition of 40% aqueous sodium hydroxide, the supernatant layer is separated, diluted with 400 ml. ether and filtered to remove tar. The filtrate is dried over sodium hydroxide and treated with methanolic hydrochloric acid to precipitate N-benzyl-N'- alpha-ethylbenzylethylenediamine dihydrochloride, which melts at about 305 C. after recrystallization from aqueous methanol.

Numerous other N,N'-bis-(mono-substituted)ethylenediamines may be prepared according to U. S. Patent #2,627,49l. Formation of N-cyclohexyl-N-ethyl-ethylenediamine is taught by this patent by reaction of acetaldehyde with N-cyclohexyl-ethylenediamine followed by catalytic hydrogenation; N-benzyl-N'-vanillyl-ethylenediamine Calculated Found A 1.5 g. sample of the imidazole was suspended in 25 ml. of 6 N HCl and heated for three hours at 100 C. The mixture was filtered and the solid product recrystallized from water to give 05 g. of N,N'-dibenzylethylenediarnine dihydrochloride. M. P.305 306 C. (d). An authentic sample gave M. P. 305307 C. (d). The filtrate contained active, regenerated streptomycin in solution.

EXAMPLE II The procedure of Example I was repeated with certain variations and the following, tabulated results.

Experiment No. Conditions and results Run 1 Run 2 Run 3 Moles of Streptomycin Sulfate 0.005 0 0 Potency of Streptomycin Sulfate 769 u./mgm 769 uJmgm Moles of Amine 0.027 0 0 0.0225. Grams of Amine... 5.4. M15. H20 50. M I s. MeOH 70.

Potency diff-55555 31111111IIIIIII Solubility in water of Product 3 Reaction Time 3.6 5.2 7.2. 245-255 0. (d.) 249-252 0. (d.) are-247 o. (1.).

2092 u.lml. 4560 u./ml.

Room temp for Room temp. for 4550 C. for 10 few hours. 3days. minutes: Room temp. 24 hours.

1 Eroduct. slurried with ml. water to remove unreacted streptomycin sulfate, collected by filtratration, air-dried and then weighed and assayed.

3 The potency of the product was determined on suspensions by bio-assay (subtilis and 0015) due to its insolubility in water, methanol, butanol, ketones, acetonitrile, nitromethane, chloroform,

dimethylformamide and amyl acetate and acetone.

The suspensions contained 10 mgms. of finelyground-produpt per ml. water.

3 The solubility of the product was determined by shaking at least 0.1 g. of finely ground material in 10 ml. water for hours, filtering the solution which contains much undissolved product and assaying the filtrate (subtilis and 0022').

is prepared by reaction of N-benzyl-ethylenediamine with vanillin followed by reduction with formic acid. In the same patent are disclosed numerous N-mono-substitutedethylenediamines (c. g. N-heptylethylenediamine) and a general process for their preparation by reaction of an aldehyde (e. g. heptaldehyde) with ethylenediamine diformate. These products can in turn be reacted as their diformates with aldehydes to give diamines of the formula R1NHCH2CH2 NH-Rz where R1 and R2 differ.

Further understanding of the invention may be obtained by reference to the following examples which are illustrative only and are not the exclusive embodiment of the invention. 1 wish it to be understood that I do not desire to be limited to the exact details shown and described, for obvious modifications will occur to a person skilled in the art.

EXAMPLE I 1,3-dibenzyZ-Z-srreptomycyltetrahydroimidazole sulfate To a solution of 7.3 g. (0.01 mole) of streptomycin sulfate in 50 ml. of water was added 5.4 g. (0.025 mol) of N,N'-dibenzylethylenediamine in 25 m1. of methanol. Addition of 45 ml. of methanol gave a clear solution. Heating on the steam bath at 45-50 C. for ten minutes caused precipitation of 1,3-dibenzyl-2-streptomcycltetrahydroimidazole sulfate as an oil which crystallized rapid- EXAMPLE III 1,3-di(dehydr0abietyl) -2-slreptomycyltetrahydroimidazole sulfate A'nalysis.-Calculated for caeHsrNsOn- 1 /2H2SO4:

Calculated Found assent EXAMPLE IV fl Y I ;3-di(dehydroabi'etyl)-2-str:eptomycyltetrahydroimidazole r *s'ulfate EXAMPLE v 1,3-dicyclohexyl-Z-streptomycyltetrahydroimidazole sulfate A solution of 2.4 grams (0.011 mole) of N,N'-dicyclohexylethylenediamine dissolved in the minimum amount of methanol is added to 7.3 g. (0.01 mole) streptomycin sulfate dissolved in 50 ml. water. The minimum amount of ethanol is added to ensure complete solution; After heating at 45 50 C. for ten minutes, the reaction mixture is allowed to stand at room temperature for three days. The product, '1,3-dicyclohexyl-2-streptomycyltetrahydroimidazole sulfate, precipitates either upon cooling or upon the addition of water and is collected by filtration or by decantation.

A 1.5 g. sample of this imidazole is heated for three hours at 100 C. in 25 ml. of 6 N HCl to regenerate the amine hydrochloride and soluble, active streptomycin.

EXAMPLE VI N,N'-bis-dehydr0abietylethylenediamine Dehydroabietylamine (190 grams), ethylene bromide (59.3 g.) and potassium carbonate (92 'g.) were mixed with 2.5 liters toluene in a flask equipped with a stirrer and refluxed overnight. The toluene solution was filtered, washed with dilute sodium hydroxide and then'two liters of water and the toluene removed by distillation to leave 175.3 g. crude product, N,N'-bis-dehydroabietylethylenediamine which was purified by distilling oil the impurities, particularly dehydroabietylamine, up to 275 C./1 mm., at which point the product begins to distill.

EXAMPLE VII N,N-bis-(t-octyl) -ethylenediamine A mixture of 650 grams (5.0 moles) of t-octylamine (Rohm and Haas, B. P. 137142 C. at 760 mm., also called l-amino-l,1,3,3-tetramethyl-n-butane) and 50 ml. of water was heated under reflux with stirring during the dropwis'e addition of 188 grams (1.0 mole) of ethylene dibromide, and heating was continued for an additional 8 hours. While still warm, the mixture was treated with 300 grams of 50% sodium hydroxide; the organic layer was separated and washed with dilute alkali and water. After drying, the material was fractionally distilled to yield about 260 grams (about 92% of theoretical) of N,N'-bis(i-octyl)-ethylenediamine boiling at 120 C. at a pressure of 0.5 mm. Hg.

EXAMPLE VIII N,N'-bis- (cyclohexylmethyl) ethylenediamine Commercially available 1,2,5,G-tetrahydrobenzaldehyde (30.0 grams; 0.272 mole) in 50 m1. methanol is mixed with 7.5 grams (0.125 mole) of anhydrous ethylenediamine. Appreciable heat is evolved and the solution turns yellow. Raney nickel catalyst (40.0 grams wet weight) washed successively with water and methanol is added and the mixture is hydrogenated with shaking in an atmosphere of hydrogen at about 50 pounds per square inch guagejat about 60 After the adsorption of about two moles ofhydrogen for each mole of tetrahydrobenzaldehyde used, the catalyst is. removed. by filtration and the solution is acidified with concentrated hydrochloric acid. White crystalline .N,N-bis (cyclohexylmethyl) ethylenediamine dihydrochloride precipitates and is collected. Upon recrystallization from water, this product melts at about 318 -319 C. with decomposition.

Anqlysis. Calculated for CwI-IzzNs-zHCl:

Calculated Found N,N'-bis(cyclohexylmethy1) ethylenediamine dihydrochloride (3.2 grams, 0.01 mole) prepared as above, is

suspended in water and neutralized with 50% sodium hydroxide. The liberated free base, N,N'-bis-(cyclohexylmethyl)-ethylenediamine, is extracted into ether. The combined ethereal extracts are washed with water and saturated sodium chloride solution and filtered through anhydrous sodium: sulfate. The solvent ether is removed by distillation, leaving the .free base as a colorless oil.

EXAMPLE IX N,N-bis-(3,5-dimethyl-2-hydroxybenzyl)-ethylenediamine tate handling, the white, crystalline dihydrochloride of N,N'-bis-(3,5 dimethyl 2 hydroxybenzyl) ethylenediamine precipitates and is collected by filtration.

After two reerystallizations from a mixture prepared from equal volumes of water and methanol to which about one-twentieth part of concentrated hydrochloric acid has been added, the product melts at about 225.5 228.5 C.

Analysisz-Calculated for CzoHsoClaNzOz:

Calculated Found The free base is liberated from the dihydrochloride with alkali in the usual manner.

EXAMPLE X N,N'-bis(olpha-methylbenzyl) -ethylenediamine Alpha-methylbenzylamine (48.4 grams, 0.4 mole) is placed in a three-necked flask fitted with stirrer, condenser and dropping funnel and arranged for heating with an electric mantle. Ethylene dibromide (18.8 grams, 0.1 mole) is dropped into the heated amine over a period of two hours. After all of the bromide is added, 8 ml. of water is added and the reaction mixture is refluxed for an additional six hours. The mixture is allowed to cool to room temperature and is then neutralized by the addition of ten grams of sodium'hydroxide in 25 mlof water. The organic'layer' is separated, dried and distilled under reduced pressure to give N,N'-bis(alpha'- methylbenzyl)ethylenediamine, boiling about 176-185 C. at 4 mm; of mercury pressures I 9 EXAMPLE XI 1,3-dibenzyl-Z-streptomycyl-tetrahydroimidazole sulfate Eight grams of solid streptomycin sulfate (potency- 475 units/mgm. by B. subtilis assay; partially purified by adsorption on and elution from ion-exchange resin columns) was dissolved in 50 ml. water and mixed with a solution of 10 mls. N,N-dibenzyl-ethylenediamine in 70 mls. methanol to give a clear solution which was heated to 50 C. for one hour. 1,3-dibenzyl-2-strcptomycyltetrahydroimidazole sulfate (7.64 grams) precipitated and was collected by filtration, dried over P205 and found to assay 600 units/mgm. The filtrate (78 mls.) assayed 2880 units/ml.

7.5 grams of this 1,3-dibenzyl-2-streptomycyl-tetrahydroimidazole sulfate were placed in water and the pH was adjusted to pH 2 with sulfuric acid. N,N'-dibenzylethylenediamine sulfate precipitated and was collected by filtration (1.04 g.). Addition of five volumes of methanol to the filtrate precipitated solid streptomycin sulfate (4.08 g.) assaying 625 u./mgm.

EXAMPLE XII Fifty mls. of streptomycin liquor assaying 182,000 units/ml. (B. subtilis assay) and obtained by elution of broth adsorbed on an ion-exchange resin column was added to 10 mls. N,N'-dibenzyl-ethylenediamine in 65 mls. methanol, liberating heat and giving a clear solution which was heated to 50 C. for one hour and then allowed to stand overnight. 1,3-dibenzyl-2-streptomycyltetrahydroimidazole sulfate precipitated and was collected by filtration, dried over P205 and found to weigh 4.1 grams and to assay 528 units/mgm. The filtrate, 39 mls., assayed 2480 units/ml.

Four grams of this 1,3-dibenzyl-2-streptomycyl-tetrahydroimidazole sulfate was placed in water and the pH was adjusted to pH 2.0 with sulfuric acid. After standing, the volume was reduced by one-half by distillation in vacuo and the N,N-dibenzylethylenediamine sulfate which precipitated (0.92 g.) was removed by filtration. The addition of five volumes methanol pre- 10 cipitated 2.53 g. streptomycin sulfate assaying 560 units/mgm; the filtrate (925 ml.) assayed 122 units/ml.

1,3-dibenzyl-Z-streptomycyl-tetrahydroimidazole sulfate (2%) in 4% aqueous acacia suspension has LDso (minimum lethal dose in of animals) of about 342:21 mgm./kg. by intraperitoneal injection in mice.

Streptomycin sulfate, 1,3-dibenzyl-Z-streptomycyl-tetrahydroimidazole sulfate and 1,3-di(beta-phenylethyl)-2- streptomycyl-tetrahydroimidazole sulfate by in vitro test all have minimum inhibitory concentrations of 0.0002 mgrnJml. against the streptomycin-sensitive strain H37RU of Mycobacterium tuberculosis and all fail to inhibit streptomycin-resistant strain H37RUR.

The CD50 (Curative Dose-50) is the minimum intraperitoneal dose of the drug which will cure 50 percent of a group of mice injected intraperitoneally with 100 to 1000 LDso doses of Diplococcus pneumoniae, each LDso dose being sufiicient if given alone to kill 50 percent of a group of mice. One-half the dose of test drug is given twenty-four hours before the simultaneous injection of the other half of the test drug and the challenge (infection). The animals are observed for four days and deaths for each group expressedas the percentage of the total animals per group. The percentage death is transformed to probit values and these plotted against the log of the dose in mgms. per kg. of mouse weight. The point of intersection of the probit 5 line and the best line constructed through the experimental points describes the concentration of drug which should protect half the animals under the conditions of the experiment. The antilog of this term is called the CD50 value. Using aqueous suspensions, including sodium carboxymethylcellulose and having pH about 7, of the two new drugs, the following values for CD50 were found as above: 6.8 mgm./kg. for streptomycin sulfate; 45 mgm./kg. for 1,3-dibenzyl-2-streptomycyltetrahydroimidazole sulfate; and mgrn./kg. for 1,3-di(betaphenethyl) -2-streptomycyltetrahydroimidazole sulfate.

I claim:

N,N-bis-dehydroabietylethylenediamine.

No references cited. 

